# Use of INTEGRA™ Flowable Wound Matrix to Manage Diabetic Foot Ulcers

> **NCT01108263** · PHASE4 · TERMINATED · sponsor: **Georgetown University** · enrollment: 5 (actual)

## Conditions studied

- Diabetes
- Foot Ulcer

## Interventions

- **DRUG:** INTEGRA™ Flowable Matrix (Collagen)

## Key facts

- **NCT ID:** NCT01108263
- **Lead sponsor:** Georgetown University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2010-06
- **Primary completion:** 2011-08
- **Final completion:** 2011-08
- **Target enrollment:** 5 (ACTUAL)
- **Why stopped:** Sponsor Terminated
- **Last updated:** 2014-03-17

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01108263

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01108263, "Use of INTEGRA™ Flowable Wound Matrix to Manage Diabetic Foot Ulcers". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01108263. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*